Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Shawn Ahmed

Diagnostic Radiology Eden Prairie, MN Medical Doctor

NPI 1942443080 CMS profile 589393

11995 Singletree Ln Ste 500, Eden Prairie, MN 55344

Open in the dashboard

General payments

$139,186

204 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Shawn Ahmed of Eden Prairie, MN is reported in the CMS Open Payments database as having received $139,186 across 204 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $31,035 27
2024 General $35,678 47
2023 General $33,129 59
2022 General $30,524 36
2021 General $8,199 23
2020 General $586 10
2019 General $36 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Shawn Ahmed
  • Diagnostic Radiology median
  • Middle half of Diagnostic Radiology
  • National median

In program year 2025, general payments to Shawn Ahmed were reported at $31,035. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.

Show as a table
Year Shawn Ahmed Diagnostic Radiology median Middle half National median
2019 $36 $108 $29–$318 $163
2020 $586 $65 $21–$252 $114
2021 $8,199 $92 $24–$292 $132
2022 $30,524 $104 $29–$294 $149
2023 $33,129 $110 $29–$337 $160
2024 $35,678 $113 $30–$356 $164
2025 $31,035 $112 $32–$349 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AngioDynamics, Inc. $132,986 43 payments
  2. Penumbra, Inc. $2,471 2 payments
  3. Boston Scientific Corporation $1,462 81 payments
  4. Inari Medical, Inc. $419 20 payments
  5. Abbott Laboratories $411 3 payments
  6. Cardiovascular Systems Inc. $405 13 payments
  7. Janssen Pharmaceuticals, Inc $286 16 payments
  8. Medtronic, Inc. $150 8 payments
  9. Stryker Corporation $131 1 payment
  10. Medtronic USA, Inc. $129 3 payments
  11. Other $336 14 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Long term medical supply or device loan $126,917 7 payments
  2. Education $5,371 2 payments
  3. Food and Beverage $4,124 191 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,400 1 payment
  5. Travel and Lodging $373 3 payments
Products named General payments · program years 2019–2025
  1. Auryon Laser System 100-120 Vac Et $95,333 4 payments
  2. Auryon Laser System 100-120 Vac Cv $25,250 1 payment
  3. VenaCure 1470 Pro Et $6,867 2 payments
  4. VenaCure 1470 Pro Id $4,800 1 payment
  5. Indigo System $2,471 2 payments
  6. CT THROMBECTOMY SYSTEM KIT $550 21 payments
  7. FLOWTRIEVER CATHETER, S $550 21 payments
  8. AURYON LASER SYSTEM 100-120 VAC Pad $519 28 payments
  9. Peripheral Orbital Atherectomy System $333 5 payments
  10. XARELTO $286 16 payments
  11. Other $2,251 93 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

165

Median for Diagnostic Radiology: 24

Drug cost

$24,556

Median for Diagnostic Radiology: $190

Branded share of claims

60%

Median for Diagnostic Radiology: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 36 $22,094
Enoxaparin Sodium Generic 25 $1,895
Clopidogrel Clopidogrel Bisulfate Brand 46 $402
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 17 $77
Triamcinolone Acetonide Generic 17 $45
Prednisone Generic 24 $43

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,198 Part D prescribers listed as Diagnostic Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 78 billing codes

Paid by Medicare

$791,339

Medicare's payments for the services billed

Medicare patients

186

Average age 76

Services billed

1,725

98 women, 88 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 72%
Arthritis 57%
Diabetes 39%
Ischemic heart disease 34%
Chronic kidney disease 34%
Depression 30%
Heart failure 25%
Atrial fibrillation 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

204 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record